21 Nov 2019 07:00
Omega Diagnostics Group PLC
("Omega" or "the Company" or the "Group")
Investor results briefing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Wednesday 4 December 2019, accompanying the interim results for six months ended 30 September 2019.
The event will take place in the No.1 Cornhill, London, EC3V 3ND at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.
The results presentation will be available on the Company website shortly after the event. No new information will be disclosed.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email omega@walbrookpr.com.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 | |
Bill Rhodes, Interim Non-Executive Chairman
| www.omegadiagnostics.com | |
Colin King, Chief Executive |
| |
Kieron Harbinson, Group Finance Director | ||
| ||
finnCap Ltd | Tel: 020 7220 0500 | |
Geoff Nash/James Thompson/Hannah Boros (Corporate Finance) | ||
Camille Gochez (ECM) | ||
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Cawthorne | Mob: 07584 391 303 | |
ODX.L (ODX)